6AU5
Structure of cetuximab with aminoheptanoic acid-linked n-butylarginine meditope variant
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | ROTATING ANODE |
Source details | RIGAKU MICROMAX-007 HF |
Temperature [K] | 100 |
Detector technology | IMAGE PLATE |
Collection date | 2012-02-15 |
Detector | RIGAKU RAXIS IV++ |
Wavelength(s) | 1.5418 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 64.580, 83.060, 211.830 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 33.173 - 2.484 |
R-factor | 0.1878 |
Rwork | 0.186 |
R-free | 0.22650 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 5id0 |
RMSD bond length | 0.005 |
RMSD bond angle | 1.023 |
Data reduction software | XDS |
Data scaling software | XSCALE |
Phasing software | MOLREP |
Refinement software | PHENIX (1.11.1_2575) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 33.173 | 2.550 |
High resolution limit [Å] | 2.480 | 2.480 |
Rmerge | 0.038 | 0.165 |
Number of reflections | 40278 | 2533 |
<I/σ(I)> | 34.8 | 9.2 |
Completeness [%] | 98.0 | 85 |
Redundancy | 5.5 | 4.3 |
CC(1/2) | 0.999 | 0.973 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 293 | 0.1 M sodium citrate, pH 4.0, 1.6 M ammonium sulfate |